The National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) announced that Eddie Reed, MD has been named as the clinical director for the NIMHD Intramural Research Program. Dr. Reed joins the NIMHD from the University of South Alabama, where he was professor of oncologic sciences and Abraham Mitchell Distinguished Investigator at the University’s Mitchell Cancer Institute in Mobile.
Dr. Reed’s clinical research has focused on the molecular pharmacology of DNA-damaging anticancer agents. He has earned two United States Public Health Service Commendation Medals for his work on the clinical development of paclitaxel (Taxol®), a chemotherapy drug given to treat ovarian, breast and non-small cell lung cancer. He has provided leadership for efforts aimed at reducing health disparities and has contributed to the development of several cancer screening and control programs. He has previously served as a tenured scientist, chief of the Clinical Pharmacology Branch, and chief of the Ovarian Cancer and Metastatic Prostate Cancer Clinic in the Division of Clinical Sciences at the National Cancer Institute (NCI), a part of the NIH; director of the Mary Babb Randolph Cancer Center at West Virginia University, Morgantown, and director of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention.
Dr. Reed earned his MD from Yale University School of Medicine. He completed internship and residency at Stanford University and a fellowship at the NCI. He served on the Institute of Medicine’s National Cancer Policy Forum from 2005–2008 and has also served on the National Advisory Council on Minority Health and Health Disparities.
GWU Names Dean of School of Medicine and Health Sciences
Jeffrey S. Akman, MD, has been appointed as vice president for health affairs, dean of the George Washington University (GWU) School of Medicine and Health Sciences (SMHS), and the Walter A. Bloedorn Chair of Administrative Medicine. …